Skip to main content

Table 4 Correlation between luminal B-like tumours and MRI features

From: Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?

   Luminal B χ2 analysis p-value Univariate analysis  
     OR (CI 95%)a p-value
No. of patients   54    
Tumour size Median (mm)
Range (mm)
20
6–86
   
 ≥ 2 cm   33/54 0.338 1.401 (0.702–2.793) 0.339
T2 intensity Hypointensity
Isointensity
Hyperintensity
29/54
9/54
16/54
0.159 1.723 (0.868–3.420)
0.469 (0.201–1.098)
0.988 (0.470–2.076)
0.120
0.081
0.974
Mass enhancement   44/54 0.881 1.069 (0.449–2.544) 0.881
Rim enhancement   16/44 0.944 1.029 (0.469–2.255) 0.944
Intralesional necrosis   23/54 0.899 0.957 (0.482–1.900) 0.899
Perilesional oedema   32/54 0.204 1.558 (0.784–3.097) 0.205
Abnormal lymph nodes   23/54 0.334 1.410 (0.702–2.831) 0.335
Intensity-to-time curve Type I
Type II
Type III
5/54
14/54
35/54
0.961 1.166 (0.351–3.877)
1.034 (0.475–2.250)
0.921 (0.451–1.882)
0.802
0.933
0.822
ADC value Very low
Low
Intermediate
29/48
19/48
0/48
0.490 0.922 (0.440–1.932)
1.213 (0.576–2.554)
Out of scale
0.830
0.611
Extent of disease Unifocal
Multifocal
Multicentric
28/54
19/54
7/54
0.025 1.526 (0.770–3.022)
1.604 (0.766–3.357)
0.298 (0.120–0.740)
0.226
0.210
0.009
  1. aOR Odds ratio, CI Confidence interval, ADC Apparent diffusion coefficient